These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19556984)

  • 1. Intrauterine subdural hemorrhage in a preterm neonate possibly associated with maternal low-molecular weight heparin treatment.
    Bauder F; Beinder E; Arlettaz R; Albisetti M; Boltshauser E; Gessler P
    J Perinatol; 2009 Jul; 29(7):521-3. PubMed ID: 19556984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin-induced fetal intracranial subdural hematoma.
    Oswal K; Agarwal A
    J Clin Ultrasound; 2008 Sep; 36(7):451-3. PubMed ID: 18361465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hemorrhage after low-molecular-weight heparin treatment in a preterm neonate.
    van Elteren HA; Te Pas AB; Kollen WJ; Walther FJ; Lopriore E
    Neonatology; 2011; 99(4):247-9. PubMed ID: 21063129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of low-molecular-weight heparins in pregnancy--how safe are they?
    Deruelle P; Coulon C
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of low molecular weight heparin therapy during labor.
    Maslovitz S; Many A; Landsberg JA; Varon D; Lessing JB; Kupferminc MJ
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):39-43. PubMed ID: 15804785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of low-molecular heparin for anticoagulation in pregnancy].
    Kelbel C; Hafner G; Schinzel H; Prellwitz W; Weilemann LS
    Dtsch Med Wochenschr; 1994 Nov; 119(44):1497-500. PubMed ID: 7956777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of deep vein thrombosis and preeclampsia. Therapeutic possibilities].
    Palot M; Daigremont-Botmans C; Visseaux H
    Ann Med Interne (Paris); 2003; 154(5-6):354-60. PubMed ID: 15027590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular mass heparin (LMMH) for management of thromboembolic disease in pregnancy.
    van Rooijen M; Bryngelsson AL; Bremme K
    Acta Obstet Gynecol Scand; 2005 Oct; 84(10):1018-9. PubMed ID: 16167922
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy.
    Santoro R; Iannaccaro P; Prejanò S; Muleo G
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):240-3. PubMed ID: 19357505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
    Blatný J; Fiamoli V
    Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboprophylaxis following caesarean section; hospital protocols are necessary.
    Pather S; Sykes P; Davis R; Reid R; Skjellerup N
    N Z Med J; 2001 Jul; 114(1136):339-40. PubMed ID: 11548102
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.
    Abildgaard U; Sandset PM; Hammerstrøm J; Gjestvang FT; Tveit A
    Thromb Res; 2009 Jul; 124(3):262-7. PubMed ID: 19162303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
    Naz R; Naz S; Mehboob M; Khalid GH
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal anticonvulsants and fetal hemorrhage. A report of two cases.
    Gimovsky ML; Petrie R
    J Reprod Med; 1986 Jan; 31(1):61-2. PubMed ID: 3950885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of thromboprophylaxis during pregnancy among specialists in maternal-fetal medicine.
    Casele HL; Grobman WA
    J Reprod Med; 2007 Dec; 52(12):1085-9. PubMed ID: 18210898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin.
    Katz VL; DiTomasso J; Farmer R; Carpenter M
    Am J Perinatol; 2002 Jul; 19(5):273-7. PubMed ID: 12152146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal survival after traumatic fetal subdural hematoma.
    Sokal MM; Katz M; Lell ME; Fox A
    J Reprod Med; 1980 Mar; 24(3):131-3. PubMed ID: 7373594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy and delivery in patients with portal vein cavernoma.
    Ducarme G; Plessier A; Thuillier C; Ceccaldi PF; Valla D; Luton D
    Gynecol Obstet Invest; 2009; 68(3):196-8. PubMed ID: 19672089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdural hemorrhages associated with antithrombotic therapy in infants with cerebral atrophy.
    Dang LT; Shavit JA; Singh RK; Joshi SM; Leber SM; Barks JD; Shellhaas RA
    Pediatrics; 2014 Sep; 134(3):e889-93. PubMed ID: 25113301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.